Skip to main content

Advertisement

SpringerLink
Log in

Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy

  • Case Report
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Walker S. Updates in non-small cell lung cancer. Clin J Oncol Nurs 2008;12:587–596.

    Article  PubMed  Google Scholar 

  2. Scagliotti GV, De Marinis F, Rinaldi M, Crino L, Gridelli C, Ricci S, et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small cell lung cancer. J Clin Oncol 2002;20:4285–4291.

    Article  PubMed  CAS  Google Scholar 

  3. Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009;361:958–967.

    Article  PubMed  CAS  Google Scholar 

  4. Chen YZ, Li ZD, Gao F, Zhang Y, Sun H, Li PP. Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer. Chin J Integr Med 2009;15:415–419.

    Article  PubMed  CAS  Google Scholar 

  5. Chen YZ, Di LJ, Zhang SL, Chen MS, Sun H, Gao F, et al. The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional Chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy. Chin J Lung Cancer (Chin) 2008;11:441–444.

    CAS  Google Scholar 

  6. Li HJ, Wang H, Fang QH, Zhang GQ. Effects of Kanglaite on apoptosis and apoptotic protein procaspase-3 and caspase-9 expression in hepatic carcinoma BEL-7404 cells. Tumor (Chin) 2010;30:740–743.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, 100142, China

    Yan-zhi Chen  (陈衍智), Zhan-dong Li  (李占东), Ning Zhou  (周 宁), Hong Sun  (孙 红) & Ping-ping Li  (李萍萍)

Authors
  1. Yan-zhi Chen  (陈衍智)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhan-dong Li  (李占东)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ning Zhou  (周 宁)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hong Sun  (孙 红)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ping-ping Li  (李萍萍)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ping-ping Li  (李萍萍).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Yz., Li, Zd., Zhou, N. et al. Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy. Chin. J. Integr. Med. 18, 626–628 (2012). https://doi.org/10.1007/s11655-012-1171-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-012-1171-2

Keywords

Search

Navigation